Trial Profile
Galantamine ER Open Label Rapid Dose Escalation Trial in Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Jan 2010
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 12 May 2009 New trial record